Skip to content

The effect of vitamin D on patients with Sepsis

Clinical trial of comparison of vitamin D and placebo on serum level of inflammatory and anti-inflammatory cytokines in patients with sepsis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016090823552N8
Enrollment
160
Registered
2016-10-05
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis. Sepsis, unspecified

Interventions

Intervention 1: Intervention group : These patients will received 1 milliliter vitamin D (300000 IU) ( institut Pasteur.Tehran .Iran ) , single dose, Intramuscularly. Intervention 2: Control group
Treatment - Drugs
Placebo
Control group : These patients will received 1 ml intramuscular, single dose of normal saline as placebo.
Intervention group : These patients will received 1 milliliter vitamin D (300000 IU) ( institut Pasteur.Tehran .Iran ) , single dose, Intramuscularly.

Sponsors

Arak University of Medical Sciences, Vice Chancellor for Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age greater than 18 years old; Sepsis diagnosis and infection source; Patients satisfaction Exclusion criteria: Calcium level greater than or equal to 10 mg/dl; Vitamin D intake during 7 days ago; History of parathyroid diseases; Metabolic bone disease; Sarcoidosis; End stage renal disease (ESRD); Impending death; Pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum Ca level. Timepoint: 3 months after injection. Method of measurement: mg/dl.;Serum Vitamin D level. Timepoint: 3 months after injection. Method of measurement: mg/dl.;Tumor necrosis factor alpha. Timepoint: 3 months after injection. Method of measurement: ELISA.;Interleukin 10. Timepoint: 3 months after injection. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Abolfazl Jokar

Vali-e-Asr hospital

dr.a.jokar@gmail.com+98 86 3223 1104

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026